Table 2

Disease process and health status measures in patients with RA from Vilnius and Oslo (mean (SD) for continuous variables, % (n/total) for dichotomous variables)

Vilnius (n=201)Oslo (n=201)p Value
VAS, visual analogue scale; TJC, tender joint count; SJC, swollen joint count; DAS, disease activity score; MHAQ, modified Health Assessment Questionnaire; RF, rheumatoid factor; ESR, erythrocyte sedimentation rate; WBC, white blood cell count; SF-36, Short Form-36 Health Survey.
Pain VAS (0–100)59.5 (20.0)36.2 (22.1)<0.001
Patient’s global assessment (1–10)49.2 (18.0)41.8 (20.0)<0.001
Investigator’s global assessment (1–100)47.5 (22.8)29.2 (24.7)<0.001
28 TJC12.6 (7.9)6.6 (6.5)<0.001
28 SJC4.7 (5.2)7.8 (6.0)<0.001
DAS285.3 (1.0)4.4 (1.4)<0.001
MHAQ (1–4)2.3 (0.8)1.6 (0.5)<0.001
RF positive61% (82/134)49% (93/190)0.03
ESR (mm/1st h)28.6 (13.4)20.5 (17.3)<0.001
Haemoglobin (g/l)118 (13)137 (13.2)<0.001
WBC (×109/l)8.0 (2.0)8.3 (2.7)0.14
Extra-articular manifestations present59% (118/200)62% (116/187)0.60
Comorbidity73% (141/192)53% (102/192)<0.001
SF-36
    Physical functioning35.2 (25.2)48.5 (25.6)<0.001
    Role physical23.1 (34.8)25.7 (33.7)0.47
    Bodily pain42.0 (21.2)42.6 (21.1)0.99
    General health23.2 (13.5)44.5 (21.3)<0.001
    Vitality43.7 (22.4)41.9 (20.9)0.25
    Social functioning61.1 (27.0)64.6 (27.3)0.26
    Role emotional34.0 (42.4)52.1 (40.3)<0.001
    Mental health54.6 (21.0)68.7 (19.7)<0.001